Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Skin cell DNA" refers to the deoxyribonucleic acid present within the nucleus of all skin cells. This molecule encodes the genetic instructions necessary for cellular function, replication, and repair. In the context of dermatology and disease, damage to this DNA—most commonly from ultraviolet (UV) radiation—can result in mutations that disrupt normal cellular behavior and may lead to malignancies such as squamous cell carcinoma or melanoma[1][4][6]. The integrity of skin cell DNA is protected by melanin production; when UV-induced damage occurs, melanocytes are signaled to increase melanin synthesis as a protective response[1][6]. However, excessive or unrepaired damage can overwhelm these defenses and result in permanent genetic alterations. While "skin cell DNA" is critical for understanding disease mechanisms like carcinogenesis or aging (e.g., telomere shortening), it is not itself a therapeutic target such as a receptor or enzyme. Instead, it represents the substrate affected by environmental insults and intrinsic aging processes[2][4]. Some therapies aim indirectly at protecting or repairing this genetic material but do not target "skin cell DNA" directly as a druggable entity. Note on correctness: The term "Skin cell DNA" does not refer to a specific molecular target but rather describes all genomic material within any type of skin cell. It lacks specificity required for structured pharmacological targeting; thus it should be flagged as an incorrect entry if used in place of an actual protein/gene/receptor/enzyme name relevant for drug development purposes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Deoxyribonucleic acid in skin cell (DNA).